Unilateral lesion of the nigrostriatal pathway decreases the response of interneurons in medial prefrontal cortex to 5-HT2A/2C receptor stimulation in the rat

Brain Research

Volumn 1312, Issue , 2010, Pages 127-137

  Zhang, Qiao Jun ^a   Wang, Shuang ^b   Liu, Jian ^b,c   Ali, Umar ^b   Gui, Zhen Hua ^b   Wu, Zhong Heng ^a   Hui, Yan Ping ^a   Wang, Yong ^b   Chen, Li ^b  

^a the Second Affiliated Hospital   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

5 HT2 receptor; Electrophysiology; Interneuron; Medial prefrontal cortex; Parkinson's disease

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; APOMORPHINE; DESIPRAMINE; DOPAMINE; OXIDOPAMINE; RITANSERIN; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SODIUM CHLORIDE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; ELECTROPHYSIOLOGY; IMMUNOCYTOCHEMISTRY; IN VIVO STUDY; INTERNEURON; MALE; NERVE CELL STIMULATION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; SPIKE WAVE; SUBSTANTIA NIGRA;

ACTION POTENTIALS; ADRENERGIC AGENTS; AMINOPYRIDINES; AMPHETAMINES; ANALYSIS OF VARIANCE; ANIMALS; APOMORPHINE; CORPUS STRIATUM; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; INDOLES; INTERNEURONS; MALE; NEURAL PATHWAYS; OXIDOPAMINE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN AGENTS; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

RATTUS;

EID: 73649110551     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.11.052     Document Type: Article

References (67)

1. 2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release. Brain Res. 825 (1999) 161-171
2. 2A receptors in pyramidal neurons of prefrontal cortex. Cereb. Cortex 14 (2004) 281-299
3. 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 40 (1991) 399-412
4. Ashby C.R., Edwards E., Harkins K., and Wang R.Y. Effects of (±)-DOI on medial prefrontal cortical cells: a microiontophoretic study. Brain Res. 498 (1989) 393-396
5. 2A receptors in the rat medial prefrontal cortex: an iontophoretic study. Synapse 17 (1994) 173-181
6. 2 receptors in the rat medial prefrontal cortex. J. Pharmacol. Exp. Ther. 252 (1990) 171-178
7. 1A serotonin receptor is located in calbindin- and parvalbumin-containing neurons of the rat brain. Brain Res. 959 (2003) 58-67
8. Benes F.M., Vincent S.L., and Molloy R. Dopamine-immunoreactive axon varicosities form nonrandom contacts with GABA-immunoreactive neurons of rat medial prefrontal cortex. Synapse 15 (1993) 285-295
9. 2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex. Naunyn-Schmiedeberg's Arch. Pharmacol. 352 (1995) 283-290
10. Breit S., Bouali-Benazzouz R., Benabid A.L., and Benazzouz A. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus, which is reversed by the lesion of the subthalamic nucleus in the rat. Eur. J. Neurosci. 14 (2001) 1833-4182
11. Bunney B.S., and Aghajanian G.K. Dopamine and norepinephrine innervated cells in the rat prefrontal cortex: pharmacological differentiation using microiontophoretic techniques. Life Sci. 19 (1976) 1783-1789
12. Buzsaki G., Geisler C., Henze D.A., and Wang X.J. Interneuron diversity series: circuit complexity and axon wiring economy of cortical interneurons. Trends Neurosci. 27 (2004) 186-193
13. 1B receptor binding in degenerative movement disorders. Brain Res. 790 (1998) 323-328
14. 2A receptors are increased in Parkinson's disease neocortex. Ann. N.Y. Acad. Sci. 861 (1998) 288-289
15. Devoto P., Flore G., Saba P., Castelli M.P., Piras A.P., Luesu W., Viaggi M.C., Ennas M.G., and Gessa G.L. 6-Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex. J. Neurosci. Res. 86 (2008) 1647-1658
16. Devoto P., Flore G., Saba P., Fa M., and Gessa G.L. Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus. BMC Neurosci. 6 (2005) 31
17. Filip M., and Cunningham K.A. Hyperlocomotive and discriminative stimulus effects of cocaine are under the control of serotonin(2C) [5-HT(2C)] receptors in rat prefrontal cortex. J. Pharmacol. Exp. Ther. 306 (2003) 734-743
18. 1A receptor expression is selectively enhanced in the striosomal compartment of chronic parkinsonian monkeys. Synapse 39 (2001) 288-296
19. Fuster J.M. The Prefrontal Cortex. Anatomy, Physiology and Neuropsychology of the Frontal Lobe (1997), Lippincott-Raven, Philadelphia
20. Gabbott P.L., Dickie B.G., Vaid R.R., Headlam A.J., and Bacon S.J. Local-circuit neurones in the medial prefrontal cortex (areas 25, 32 and 24b) in the rat: morphology and quantitative distribution. J. Comp. Neurol. 377 (1997) 465-499
21. Gorelova N., Seamans J.K., and Yang C.R. Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex. J. Neurophysiol. 88 (2002) 3150-3166
22. Grobin A.C., and Deutch A.Y. Dopaminergic regulation of extracellular g-aminobutyric acid levels in the prefrontal cortex of the rat. J. Pharmacol. Exp. Ther. 285 (1998) 350-357
23. Guiard B.P., El Mansari M., Merali Z., and Blier P. Functional interactions between dopamine, serotonin and norepinephrine neurons: an in vivo electrophysiological study in rats with monoaminergic lesions. Int. J. Neuropsychopharmacol. 11 (2008) 625-639
24. Halliday G.M., Blumbergs P.C., Cotton R.G.H., Blessing W.W., and Geffen L.B. Loss of brainstem serotonin and substance P-containing neurons in Parkinson's disease. Brain Res. 510 (1990) 104-107
25. Hornung J.P., and Celio M.R. The selective innervation by serotoninergic axons of calbindin-containing interneurons in the neocortex and hippocampus of the marmoset. J. Comp. Neurol. 320 (1992) 457-467
26. Huo F.Q., Chen T., Lv B.C., Wang J., Zhang T., Qu C.L., Li Y.Q., and Tang J.S. Synaptic connections between GABAergic elements and serotonergic terminals or projecting neurons in the ventrolateral orbital cortex. Cereb. Cortex 19 (2009) 1263-1272
27. Kostic V.S., Djururicic B.M., Covickovic-Sternic N., Bumbasirevic L., Nikolic M., and Mrsulja B.B. Depression and Parkinson's disease: possible role of serotonergic mechanisms. J. Neurol. 234 (1987) 94-96
28. Kroeze W.K., and Roth B.L. The molecular biology of serotonin receptors: therapeutic implications for the interface of mood disorders and psychosis. Biol. Psychiatry 44 (1998) 1128-1142
29. 2 dopamine receptor subtypes. Mol. Brain Res. 58 (1998) 231-236
30. 2C receptor localization in GABA neurons of the rat medial prefrontal cortex: implications for understanding the neurobiology of addiction. Neuroscience 146 (2007) 1677-1688
31. Mantz J., Milla J., Glowinski J., and Thierry A.M. Differential effects of ascending neurons containing dopamine and noradrenaline in the control of spontaneous activity and of evoked responses in the rat prefrontal cortex. Neuroscience 27 (1988) 517-526
32. 2A receptor antagonist. Eur. J. Pharmacol. 259 (1994) 137-141
33. Mayeux R., Sterss Y., Cote L., and Williams J.B.W. Altered serotonin metabolism in depressed patients with Parkinson's disease. Neurology 34 (1984) 642-646
34. Meltzer H.Y. The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 21 (1999) S106-S115
35. Miller E.K., and Cohen J.D. An integrative theory of prefrontal cortex function. Ann. Rev. Neurosci. 24 (2001) 167-202
36. 3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon. J. Neurosci. 17 (1997) 3157-3167
37. Morrison J.H., Molliver M.E., Grzanna R., and Coyle J.T. The intracortical trajectory of the coeruleo-cortical projection in the rat: a tangentially organized cortical afferent. Neuroscience 6 (1981) 139-158
38. O'Hearn E., and Molliver M.E. Organization of raphe-cortical projections in rat: a quantitative retrograde study. Brain Res. Bull. 13 (1984) 709-726
39. Papadopoulos G.C., Parnavelas J.G., and Buijs R.M. Light and electron microscopic immunocytochemical analysis of the serotonin innervation of the rat visual cortex. J. Neurocytol. 16 (1987) 883-892
40. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 5th ed. (2005), Academic Press, New York
41. Pillon B., Dubois B., Cusimano G., Bonnet A.M., Lhermite F., and Agid Y. Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?. J. Neurol. Neurosurg. Psychiatry 52 (1989) 201-206
42. 1A receptor in the rat brain: correlation with receptor binding. J. Neurosci. 12 (1992) 440-453
43. 2C receptors. Mol. Brain Res. 23 (1994) 163-178
44. 2A receptors: relationship to thalamocortical afferents. Cereb. Cortex 13 (2003) 1870-1882
45. 2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb. Cortex 14 (2004) 1100-1109
46. Scatton B., Javoy-Agid F., Rouquier L., Dubois B., and Agid Y. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res. 275 (1983) 321-328
47. Scholtissen B., Verhey F.R., Steinbusch H.W., and Leentjens A.F. Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data. J. Neural Transm. 113 (2006) 59-73
48. Seguela P., Watkins K.C., and Descarries L. Ultrastructural relationships of serotonin axon terminals in the cerebral cortex of the adult rat. J. Comp. Neurol. 289 (1989) 129-142
49. Seguela P., Watkins K.C., Geffard M., and Descarries L. Noradrenaline axon terminals in adult rat neocortex: an immunocytochemical analysis in serial thin sections. Neuroscience 35 (1990) 249-264
50. Sesack S.R., Snyder C.L., and Lewis D.A. Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex. J. Comp. Neurol. 363 (1995) 264-280
51. 2 receptors in interneurons. Synapse 9 (1991) 208-218
52. Smiley J.F., and Goldman-Rakic P.S. Serotonergic axons in monkey prefrontal cerebral cortex synapse predominantly on interneurons as demonstrated by serial section electron microscopy. J. Comp. Neurol. 367 (1996) 431-443
53. Thierry A.M., Mantz J., and Glowinski J. Influence of dopaminergic and noradrenergic afferents on their target cells in the rat medial prefrontal cortex. Adv. Neurol. 57 (1992) 545-554
54. Tierney P.L., Degenetais E., Thierry A.M., Glowinski J., and Gioanni Y. Influence of the hippocampus on interneurons of the rat prefrontal cortex. Eur. J. Neurosci. 20 (2004) 514-524
55. Tseng K.Y., Mallet N., Toreson K., Moine C.L., Gonon F.O., and O'Donnell1 A.P. Excitatory response of prefrontal cortical fast-spiking interneurons to ventral tegmental area stimulation in vivo. Synapse 59 (2006) 412-417
56. 2 receptors in rat medial prefrontal cortex. J. Neurosci. 13 (1993) 2551-2564
57. 2 receptors in rat medial prefrontal cortex. Synapse 19 (1995) 112-120
58. 2 receptor expression in the prefrontal cortex of 6-hydroxydopamine-induced Parkinsonian rats. Brain Res. 1045 (2005) 229-233
59. 2A/2C receptors in the firing activity of pyramidal neurons of medial prefrontal cortex in a rodent model of Parkinson's disease. Exp. Neurol. 219 (2009) 239-248
60. 1A receptor stimulation in a rat model of Parkinson's disease. Neuroscience 162 (2009) 1091-1100
61. 1A receptor stimulation in the rat. Neuroscience 159 (2009) 850-861
62. 2A receptors in working memory. J. Neurosci. 22 (2002) 2843-2854
63. 2A receptors are expressed on pyramidal neurons and interneurons in the rat cortex. Synapse 27 (1997) 79-82
64. Zesiewicz T.A., and Hauser R.A. Depression in Parkinson's disease. Curr. Psychiatry Rep. 4 (2002) 69-73
65. 2 receptor mRNAs in striatum and subthalamic nucleus in Parkinson's disease model. Physiol. Behav. 92 (2007) 29-33
66. Zhou F.M., and Hablitz J.J. Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex. J. Neurophysiol. 82 (1999) 2989-2999
67. Ziemssen T., and Reichmann H. Non-motor dysfunction in Parkinson's disease. Parkinsonism Relat. Disord. 13 (2007) 323-332